Evidence map›Paper›PMID 41113742›Full record

ArticleInternational archives of otorhinolaryngology2025

Prevalence of Cholesteatoma in School Children of Nepal.

Milan Maharjan, Samira Rajbhandari, Shristi Subba, Anjani Gupta

Abstract read
In one paragraph

Article in International archives of otorhinolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Milan MaharjanDepartment of Ear, Nose, and Throat, Ear Care Nepal, Star Hospital, Sanepa Height, Lalitpur, Nepal.
Samira RajbhandariDepartment of Ear, Nose, and Throat, Ear Care Nepal, Star Hospital, Sanepa Height, Lalitpur, Nepal.ORCID 0009-0004-2470-1562
Shristi SubbaDepartment of Ear, Nose, and Throat, Ear Care Nepal, Star Hospital, Sanepa Height, Lalitpur, Nepal.
Anjani GuptaDepartment of Ear, Nose, and Throat, Ear Care Nepal, Star Hospital, Sanepa Height, Lalitpur, Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cholesteatoma remains a serious condition that poses a challenge to otolaryngologists around the world. It is found to be more aggressive in the pediatric group than in adults. If left untreated, the disease can be dangerous due to its ability to expand and destroy bones, leading to complications such as hearing loss, vestibular dysfunction, facial paralysis, and intracranial infections. Objective: To find out the prevalence of cholesteatoma in the school-aged children of Nepal. Methods: This is a retrospective study conducted within a span of 10 years from 2014 to 2024 in which all medical records of the school-based ear screening programs were studied. Data including personal details, brief history, and ear and audiometry findings were recorded. All suspected cases of cholesteatoma were reexamined under microscope at our institute, and only those with confirmed diagnosis of chronic otitis media (COM) with cholesteatoma were included in the study. Results: Out of the total of 143,544 children screened, COM with cholesteatoma was diagnosed in 0.20% (n = 282), and COM in total in 7.56% (n = 10,853). Hearing loss was seen in 273 (96.81%) of the 282 cases, with conductive hearing loss being the most common type of hearing loss. Conclusion: There is a higher prevalence of cholesteatoma in Nepalese children. Early diagnosis with proper management helps reduce the chances of life-threatening complications. Thus, having regular screening programs in school children will help in reducing morbidity.

Indexed as

childrencholesteatomahearing lossNepalprevalence

Identifiers

PMID41113742
PMCPMC12530909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.